Related Experiment Video
Updated: Jan 10, 2026

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
Published on: November 22, 2024
Mooren's ulcer: a multifactorial autoimmune peripheral ulcerative keratitis and current treatment protocols
Shangkun Ou1,2,3,4, Yujie Zhang2, Yuchong Feng4
1Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
None:
Mooren's Ulcer (MU) is a rare, chronic, and painful form of autoimmune peripheral ulcerative keratitis (PUK), with an elusive etiology and a risk of corneal perforation and vision loss. Despite numerous proposed triggers, including parasitic infections, hepatitis C virus, ocular trauma, and surgery, the pathogenesis of MU remains unclear, and diagnosis continues to rely heavily on exclusion. A key controversy in current clinical practice lies in the absence of standardized diagnostic criteria and consensus treatment protocols. This review addresses this gap by presenting a comprehensive and structured diagnostic framework for MU, particularly emphasizing laboratory and immunological testing strategies to facilitate accurate differential diagnosis. To our knowledge, this is the first review to systematize these diagnostic components in detail. In addition to summarizing the latest findings on epidemiology, etiology, pathology, and classification, the work also review the evolving role of advanced imaging, histopathology, and tear-based markers in MU diagnosis and monitoring. Treatment options, ranging from immunosuppressive therapy to surgical intervention, are discussed based on disease severity. This work recommend a tiered, individualized approach to treatment and advocate for future multicenter studies to validate diagnostic protocols and establish evidence-based clinical guidelines.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.

